Welcome to our dedicated page for Gentex SEC filings (Ticker: GNTX), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Gentex Corporation's SEC filings document recurring financial-reporting, governance and capital-allocation disclosures for an operating technology supplier. Recent Form 8-K reports furnish quarterly and annual earnings releases, including net sales, margins, operating income, share repurchases, and separate references to core Gentex results and VOXX contributions after the completed acquisition.
Proxy materials cover board elections, shareholder voting matters, executive compensation, equity awards and related governance disclosures. The filing record frames Gentex's public-company reporting around its digital vision, connected car, dimmable glass, fire protection, medical device and consumer electronics businesses.
GENTEX CORP director Joseph B. Anderson Jr. reported an open-market sale of 5,939 shares of Common Stock on May 15, 2026 at an average price of $22.9752 per share. Following this transaction, his directly held Common Stock position reported in this filing is 0 shares.
Gentex Corporation reported higher first-quarter 2026 results, helped by its VOXX acquisition and steady core operations. Net sales rose to $675.4 million from $576.8 million, a 17% increase, with VOXX contributing $88.6 million and core Gentex revenue edging up despite lower global light vehicle production.
Gross margin improved to 33.8%, supported by operational efficiencies and better product mix, partly offset by tariffs and commodity costs. GAAP net income attributable to Gentex increased to $98.5 million from $94.9 million, and diluted EPS rose to $0.46 from $0.42. Non‑GAAP adjusted diluted EPS was $0.48, versus $0.43 a year earlier.
The company recorded a $2.8 million impairment on Vaporsens in‑process R&D and a $2.7 million impairment on a technology investment, along with a $2.2 million increase in credit loss allowances on loans to technology investees. Gentex ended the quarter with $164.8 million in cash and cash equivalents and generated $137.1 million in operating cash flow.
Gentex Corp director Leslie L. Brown reported a combination of option exercises and share sales. On May 5, 2026, Brown sold 10,782 shares of Gentex common stock in an open-market sale at a weighted average price of $22.847 per share.
On the same date, Brown exercised stock options to acquire a total of 14,000 shares of common stock, including 7,000 options at $18.70 and 7,000 options at $15.74 per share. Following these transactions, Brown directly owned 40,144 common shares. The exercised options came from non‑employee director grants originally exercisable in 2016 and 2017 with expirations in 2026 and 2027.
Gentex Corp director Richard O. Schaum exercised stock options and sold shares in a routine portfolio move. He exercised options covering 7,000 shares of Common Stock at $15.74 per share and sold 4,815 Common shares in an open‑market sale at a weighted average price of $23.312.
Following these transactions, Schaum directly owns 81,443 Gentex Common shares. No remaining derivative option position is reported in this filing.
Vanguard Capital Management reports beneficial ownership of 11,377,317 shares of Gentex Corp common stock, representing 5.28% of the class as of 03/31/2026. The filing states Vanguard Capital Management has sole dispositive power over 11,377,317 shares and sole voting power over 1,675,976 shares. The disclosure explains holdings include securities managed across Vanguard business divisions and funds and was signed on 04/29/2026.
Gentex Corporation reported strong first quarter 2026 results with consolidated net sales of $675.4 million, up 17% from $576.8 million a year earlier. VOXX contributed $88.6 million of revenue, while core Gentex revenue was $586.8 million, a 2% increase despite lower global light vehicle production.
Consolidated gross margin was 33.8% versus 33.2% last year, with core Gentex gross margin improving to 34.0%, an 80 basis-point gain driven by operational efficiencies and favorable product mix. GAAP net income attributable to Gentex was $98.5 million and diluted EPS was $0.46, compared with $94.9 million and $0.42 in the prior-year quarter; adjusted net income was $103.7 million and adjusted diluted EPS was $0.48.
The company raised its 2026 consolidated revenue guidance to $2.65–$2.75 billion while maintaining margin and cost outlooks, and introduced 2027 revenue guidance of $2.80–$2.90 billion. Gentex repurchased 3.3 million shares for $71.6 million and highlighted ongoing technology launches, VOXX integration progress, and exposure to tariff-related costs and potential IEEPA tariff refunds.
Gentex Corporation is asking shareholders to vote at its May 21, 2026 annual meeting on electing nine directors, ratifying Ernst & Young LLP as auditor, approving say‑on‑pay, and adopting the 2026 Omnibus Incentive Plan to govern future equity and incentive awards.
For 2025, net sales were $2.53 billion, up 10% from 2024, while net income attributable to Gentex was $384.8 million and diluted EPS was $1.74, slightly below prior years. The proxy highlights strong governance practices, expanded ESG and sustainability reporting, and extensive human capital and inclusion initiatives.
Gentex Corp: Schedule 13G/A — The Vanguard Group reports zero beneficial ownership following internal realignment. The filing amends prior disclosures to state that, after an internal realignment effective January 12, 2026, The Vanguard Group and certain subsidiaries will report holdings separately. The Schedule 13G/A shows 0 shares beneficially owned and 0% of the class as reported in the amendment dated 03/13/2026, and is signed on 03/26/2026.